Emergent BioSolutions (EBS) Current Deferred Tax Assets (2010 - 2015)

Emergent BioSolutions has reported Current Deferred Tax Assets for 6 years, with the latest figure at $1.5 million in Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $1.5 million in Q3 2015; TTM through Sep 2015 was $1.5 million, a N/A change from a year earlier, with the FY2014 full-year figure at $1.7 million, changed N/A from the prior year.
• Current Deferred Tax Assets was $1.5 million for Q3 2015 at Emergent BioSolutions, roughly flat from $1.5 million in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $7.2 million in Q3 2011, with the low at $327000.0 in Q3 2012.
• Average Current Deferred Tax Assets over 5 years is $2.1 million, with a median of $1.4 million recorded in 2012.
• The sharpest annual moves came in 2012 and 2013: Current Deferred Tax Assets tumbled 95.46% in 2012, then surged 286.54% in 2013.
• Over 5 years, Current Deferred Tax Assets stood at $1.7 million in 2011, then dropped by 27.15% to $1.3 million in 2012, then changed by 0.0% to $1.3 million in 2013, then soared by 35.28% to $1.7 million in 2014, then declined by 13.27% to $1.5 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $1.5 million (Q3 2015), $1.5 million (Q2 2015), and $1.7 million (Q1 2015), per Business Quant data.